News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
484,673 Results
Type
Article (8036)
Company Profile (140)
Press Release (476592)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166747)
Career Advice (305)
Deals (25738)
Drug Delivery (7)
Drug Development (52876)
Employer Resources (14)
FDA (9760)
Job Trends (8575)
News (238194)
Policy (17906)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (4)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (486)
Accelerated approval (24)
ADA (18)
Adcomms (1)
Allergies (96)
Alliances (33154)
ALS (105)
Alzheimer's disease (975)
Antibody-drug conjugate (ADC) (263)
Approvals (10375)
Artificial intelligence (320)
ASCO (159)
Autoimmune disease (205)
Automation (28)
Bankruptcy (262)
Best Places to Work (6959)
BIO (36)
Biologics (2)
BIOSECURE Act (1)
Biosimilars (109)
BioSpace Insights (17)
Biotechnology (88)
Bladder cancer (138)
Brain cancer (29)
Breast cancer (508)
Cancer (3647)
Cardiovascular disease (217)
Career advice (245)
Career pathing (1)
CAR-T (172)
Celiac Disease (1)
Cell therapy (476)
Cervical cancer (34)
Clinical research (47867)
Collaboration (1245)
Commercialization (3)
Compensation (1470)
Complete response letters (34)
COVID-19 (754)
CRISPR (63)
C-suite (747)
Cystic fibrosis (85)
Data (5652)
Denatured (4)
Depression (102)
Dermatology (61)
Diabetes (343)
Diagnostics (4186)
Digital health (39)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (155)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (163)
Earnings (73716)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (87613)
Executive appointments (701)
FDA (12388)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (23)
Funding (919)
Gene editing (125)
Generative AI (9)
Gene therapy (318)
GLP-1 (290)
Government (942)
Grass and pollen (2)
Guidances (281)
Healthcare (9316)
Hematology (94)
HIV (52)
Huntington's disease (22)
IgA nephropathy (64)
Immunology and inflammation (98)
Immuno-oncology (56)
Indications (157)
Infectious disease (942)
Inflammatory bowel disease (126)
Inflation Reduction Act (4)
Influenza (84)
Intellectual property (255)
Interviews (41)
IPO (12387)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (16)
Layoffs (59)
Legal (5195)
Licensing (8)
Liver cancer (44)
Longevity (17)
Lung cancer (509)
Lymphoma (250)
Machine learning (27)
Management (3)
Manufacturing (534)
Marketing (8)
MASH (118)
Medical device (8655)
Medtech (8800)
Mergers & acquisitions (14383)
Metabolic disorders (706)
mRNA (55)
Multiple sclerosis (102)
NASH (4)
Neurodegenerative disease (220)
Neuropsychiatric disorders (39)
Neuroscience (1824)
NextGen: Class of 2026 (3150)
Non-profit (841)
Obesity (223)
Opinion (10)
Ovarian cancer (158)
Pain (172)
Pancreatic cancer (196)
Parkinson's disease (201)
Partnered (12)
Patents (476)
Patient recruitment (507)
Peanut (31)
People (41234)
Pharmaceutical (30)
Pharmacy benefit managers (8)
Phase 1 (15466)
Phase 2 (21375)
Phase 3 (14400)
Pipeline (7324)
Policy (18)
Postmarket research (1570)
Preclinical (6539)
Press Release (34)
Prostate cancer (189)
Psychedelics (7)
Radiopharmaceuticals (189)
Rare diseases (571)
Real estate (3019)
Recruiting (6)
Regulatory (14818)
Reports (21)
Research institute (581)
Resumes & cover letters (45)
Rett syndrome (41)
RNA editing (5)
RSV (48)
Schizophrenia (100)
Series A (156)
Series B (121)
Service/supplier (5)
Sickle cell disease (63)
Spinal muscular atrophy (88)
Sponsored (5)
Startups (2019)
Stomach cancer (3)
Supply chain (50)
Vaccines (322)
Venture capital (17)
Weight loss (73)
Women's health (79)
Date
Today (9)
Last 7 days (201)
Last 30 days (1544)
Last 365 days (19003)
2026 (12303)
2025 (19251)
2024 (22986)
2023 (26538)
2022 (34594)
2021 (37169)
2020 (33471)
2019 (23275)
2018 (17468)
2017 (18766)
2016 (17917)
2015 (24268)
2014 (21679)
2013 (18138)
2012 (20221)
2011 (20440)
2010 (20332)
Location
Africa (228)
Alabama (73)
Alaska (2)
Arizona (305)
Arkansas (11)
Asia (17889)
Australia (2098)
California (11969)
Canada (3148)
China (524)
Colorado (484)
Connecticut (409)
Delaware (208)
Europe (24628)
Florida (1789)
Georgia (380)
Hawaii (3)
Idaho (46)
Illinois (699)
India (51)
Indiana (314)
Iowa (15)
Japan (399)
Kansas (101)
Kentucky (30)
Louisiana (27)
Maine (26)
Maryland (1202)
Massachusetts (7854)
Michigan (307)
Minnesota (559)
Mississippi (4)
Missouri (82)
Montana (20)
Nebraska (11)
Nevada (116)
New Hampshire (60)
New Jersey (2620)
New Mexico (12)
New York (2822)
North Carolina (1278)
North Dakota (4)
Northern California (5996)
Ohio (278)
Oklahoma (14)
Oregon (16)
Pennsylvania (2253)
Puerto Rico (20)
Rhode Island (30)
South America (406)
South Carolina (76)
South Dakota (1)
Southern California (4971)
Tennessee (120)
Texas (1940)
United States (38866)
Utah (360)
Vermont (1)
Virginia (153)
Washington D.C. (38)
Washington State (928)
West Virginia (1)
Wisconsin (73)
Wyoming (1)
484,673 Results for "cryolife inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
CryoLife Announces Corporate Rebranding and Changes Name to Artivion
CryoLife, Inc., a leading cardiac and vascular surgery company focused on aortic disease, announced that it was renaming and rebranding itself to Artivion, Inc., effective immediately.
January 18, 2022
·
2 min read
Press Releases
Tevogen Bio Holdings Inc. Becomes Tevogen Inc.
July 29, 2026
·
4 min read
Business
Anthony Semedo Joins CryoLife Board of Directors
CryoLife, Inc., a leading cardiac and vascular surgery company focused on aortic disease, announced the appointment of Anthony “Tony” Semedo to its Board of Directors effective October 1, 2021.
September 22, 2021
·
2 min read
Business
CryoLife Reports Third Quarter 2021 Financial Results
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today its financial results for the third quarter ended September 30, 2021.
November 4, 2021
·
17 min read
Business
CryoLife Reports Second Quarter 2021 Financial Results
CryoLife, Inc., a leading cardiac and vascular surgery company focused on aortic disease, announced its financial results for the second quarter ended June 30, 2021.
July 29, 2021
·
16 min read
Deals
CryoLife Announces Sale of PerClot to Baxter
CryoLife, Inc., a leading cardiac and vascular surgery company focused on aortic disease, announced that it has completed the sale of its PerClot product line to a subsidiary of Baxter International, Inc., for up to $60.8 million in cash.
July 29, 2021
·
4 min read
BioMidwest
CryoLife to Participate in Upcoming Virtual Investor Conferences - Aug 02, 2021
CryoLife, Inc., a leading cardiac and vascular surgery company focused on aortic disease, announced that it will participate in two upcoming virtual investor conferences.
August 2, 2021
·
1 min read
Business
CryoLife Reports First Quarter 2021 Financial Results
CryoLife, Inc., a leading cardiac and vascular surgery company focused on aortic disease, announced its financial results for the first quarter ended March 31, 2021.
April 29, 2021
·
14 min read
Deals
CryoLife Acquires Ascyrus Medical
CryoLife, Inc., a leading cardiac and vascular surgery company focused on aortic disease, announced that it has acquired Ascyrus Medical LLC.
September 2, 2020
·
9 min read
CryoLife to Participate in Upcoming Virtual Investor Conferences
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in two upcoming virtual investor conferences. CryoLife’s manage
August 6, 2020
·
1 min read
1 of 48,468
Next
